Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

Pembrolizumab

The FDA approved the drug to treat melanoma, lung cancer, head and neck cancer, triple-negative breast cancer, Hodgkin lymphoma and gastric cancer. It is administered intravenously.

Categories: Oncology drugs, skin / lymph

Share:

Health Classification

Let us work together to protect precious health

More